Source map — Novartis Says Pelacarsen Heart Disease Drug Missed Primary Endpoint
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| reuters.com | news | 60% |
| Bioengineer.org | news | 60% |
| Yahoo Finance | news | 60% |
| The New York Times | news | 60% |
| WSJ | news | 60% |
| www.marketbeat.com | news | 50% |
| stockanalysis.com | news | 50% |
| hemostasistoday.com | news | 50% |
| pauldthompsonmd.substack.com | news | 50% |
| www.ajmc.com | news | 50% |
| ctv.veeva.com | news | 50% |
| ecgwaves.com | news | 50% |
| www.medscape.com | news | 50% |
| swissobserver.ch | news | 50% |
| www.masters-of-longevity.com | news | 50% |
| www.pharmacytimes.com | news | 50% |
| trial.medpath.com | news | 50% |
| www.trialticker.com | news | 50% |
| www.simianx.ai | news | 50% |
| www.europesays.com | news | 50% |
| pubmed.ncbi.nlm.nih.gov | gov | 50% |
| www.clinicaltrialvanguard.com | news | 50% |
| www.marketscreener.com | news | 50% |
| www.yahoo.com | news | 50% |
| finance.yahoo.com | news | 50% |
| www.globalbankingandfinance.com | news | 50% |
| blockonomi.com | news | 50% |
| european-biotechnology.com | news | 50% |
| www.briefs.co | news | 50% |
| wdez.com | news | 50% |
| pharmaphorum.com | news | 50% |
| imedic.health | news | 50% |
| allsci.com | news | 50% |
| eu.36kr.com | news | 50% |
| www.findarticles.com | news | 50% |
| medicalxpress.com | news | 50% |
| www.thecardiologyadvisor.com | news | 50% |
| www.ad-hoc-news.de | news | 50% |
| www.genengnews.com | news | 50% |